🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II tests the safety, side effects, best dose and how well givi...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2025-11-12
Trial ID
NCT07150806
Treatments Being Tested
This is a phase I study to evaluate the safety and preliminary efficacy of ...
Status
Recruiting
Location
Peking University Cancer Hospital & Institute
Start Date
2026-01-20
Trial ID
NCT07413042
Treatments Being Tested
This is a phase I study to assess the safety and efficacy of \[225Ac\]Ac-DO...
Status
Recruiting
Location
Peking University Cancer Hospital & Institute
Start Date
2024-09-29
Trial ID
NCT06732505
Treatments Being Tested
Phase 1b/2 open-label trial of 225Ac-DOTATATE (RYZ101) in subjects with ER+...
Status
Active Not Recruiting
Location
Research Facility
Start Date
2024-07-19
Trial ID
NCT06590857
Treatments Being Tested
This study aims to determine the safety and the recommended phase II dose o...
Status
Withdrawn
Location
Jules Bordet Institute
Start Date
2024-10
Trial ID
NCT06411301
Treatments Being Tested
This study aims to determine the safety, preliminary antitumor activity, an...
Status
Active Not Recruiting
Location
Research Facility
Start Date
2022-10-10
Trial ID
NCT05595460